Gastrointestinal Complication
17
6
6
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
90.0%
+3.5% vs benchmark
18%
3 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Effect of Abdominal Massage and Bed Exercise on Palliative Care Patients
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
Probiotics for Improving Post-surgical Healing
Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment
Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
Kefir Versus Milk on Time-Trial Performance in Masters Athletes
Collection and Distribution of Biospecimens for Novel Research
Collection and Distribution of Biospecimens for Novel Research Uses
Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients
Tolerance of Regular Meal Intake With Mycoprotein (TOMMY)
Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis
Duckweed Intake Study
Bariatric Surgery and Weight Loss on Energy Metabolism and Insulin Sensitivity
Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC)